Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Transactions of the American Ophthalmological Society|January 1, 1985
Expulsive hemorrhage: its incidence in cataract surgery and a report of four bilateral casesJ W Payne, A J Kameen, A D Jensen, et al.
Nucleic Acids Research|April 2, 1999
Human DNA topoisomerase I-mediated cleavage and recombination of duck hepatitis B virus DNA in vitroP Pourquier, A D Jensen, S S Gong, et al.
Chemical Communications (Cambridge, England)|October 29, 2014
One-step synthesis of bismuth molybdate catalysts via flame spray pyrolysis for the selective oxidation of propylene to acroleinK Schuh, W Kleist, M Høj, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|March 1, 1986
Methacholine sensitivity and cAMP protein kinase in tracheal smooth muscleA D Jensen, A M Puckett, G A Rinard, et al.
Molecular Psychiatry|August 28, 2013
De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorderP J Hamilton, N G Campbell, S Sharma, et al.
Survey of Ophthalmology|January 1, 1975
Intraocular reticulum-cell sarcoma: clinico-pathologic study of four cases and review of the literatureC C Barr, W R Green, J W Payne, et al.
HNO|May 17, 2008
[What is the impact of new radiotherapy techniques?]F Sterzing, M W Münter, A D Jensen, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 11, 2011
Whole-abdominal IMRT for advanced ovarian carcinoma: planning issues and feasibilityA D Jensen, S Nill, N Rochet, et al.
Radiation Oncology (London, England)|July 9, 2016
Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: do non-ACCs profit from dose escalation?A D Jensen, M Poulakis, V Vanoni, et al.
Clinical and Translational Radiation Oncology|October 30, 2018
Phase II study of induction chemotherapy with docetaxel, cisplatin, 5-fluorouracil followed by radioimmunotherapy with cetuximab and intensity-modulated radiotherapy in combination with a carbon ion boost for locally advanced tumors of the oro-, hypopharynx and larynxH Hauswald, A D Jensen, J Krauss, et al.
Pageof 8